CURAKNE caps moll 5 mg 30 pce

7680568850106 CH-56885 D10BA01 10.02.0.

Reimbursement limitations:

ROACCUTANE

Formes graves de l'acné, résistantes à la thérapie.

CURAKNE caps moll 5 mg 30 pce
CURAKNE caps moll 5 mg 30 pce
CURAKNE caps moll 5 mg 30 pce
1 / 3
google

Details

Product number
5688504
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
isotretinoinum 5 mg, excipiens pro capsula.

Articles (1)

Curakne 5 mg, Weichkapseln
Weichkapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/06/2025
Patient information leaflet
Français
05/06/2025
Patient information leaflet
Italien
05/06/2025
Professional SmPC
Allemand
05/06/2025
Professional SmPC
Français
05/06/2025
Professional SmPC
Italien
05/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
sojae oleum
52.1 MG Substance HBESI
cera flava
- Substance HNIDK
oleum vegetabile hydrogenatum
- Substance HNIDK
gelatina
- Substance HNIDK
glycerolum
- Substance HNIDK
aqua purificata
- Substance HNIDK
lecithinum
- Substance HNIDK
triglycerida media
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
ethanolum
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 172 (nigrum)
- Substance FTODK
polyvinylis acetas phtalas
- Substance HNIDK
aqua purificata
- Substance HNIDK
alcohol isopropylicus
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammonii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 16.35
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2006

Authorization holder

Pierre Fabre Pharma SA

4052 Basel

Authorization information

Swissmedic authorization number
56885
Drug name
Curakne, Weichkapseln
Galenic form
KAPWE
ATC Code
D10BA01
Authorization status
Z
Dispensation category
A
First authorization
05/10/2004
Authorization expiration date
31/12/9999
IT number
10.02.0.
Domain
Human medicine
Field of application
Schwere therapieresistente Formen von Akne

Packaging details

Description (FR)
CURAKNE caps moll 5 mg 30 pce
Description (DE)
CURAKNE Weichkaps 5 mg 30 Stk
Market launch
07/04/2006
Narcotic (BTM)
No

Other packaging sizes

CURAKNE caps moll 10 mg 30 pce
30 KAP
View
CURAKNE caps moll 10 mg 100 pce
100 KAP
View
CURAKNE caps moll 20 mg 30 pce
30 KAP
View
CURAKNE caps moll 20 mg 100 pce
100 KAP
View
CURAKNE caps moll 5 mg 100 pce
100 KAP
View
CURAKNE caps moll 40 mg 30 pce
30 KAP
View